Dosage and administration subtopic
| |
Articles
1-52 out of 52 article(s)
| Title |
Author |
Type |
Date |
Words |
| Hemoglobin expression in the hypothalamus of mice following atypical antipsychotic Drug Treatment. |
|
Brief article |
Apr 1, 2009 |
302 |
| The cause of 36,000 deaths annually: "the unholy alliance" between psychiatrists and drug companies. |
Mercola, Joseph; Gerson, Charlotte |
|
Mar 1, 2009 |
584 |
| Antipsychotics for aggression unrelated to a psychiatric diagnosis. |
Levitas, Andrew S.; Turk, Jeremy; Bramble, David; Hurley, Anne D. |
|
Apr 1, 2008 |
2201 |
| Sedative drugs increase risk of early death in Alzheimer's patients. |
|
Brief article |
Apr 9, 2007 |
217 |
| Off-label use of atypical anti-psychotics may be ineffective, says AHRQ. |
|
|
Jan 29, 2007 |
790 |
| Adopting person-centered care in nursing homes. |
|
|
Jan 1, 2007 |
1183 |
| Schizophrenia, substance use need integrated Tx: take into account the possible synergistic effects between antipsychotics and drugs of abuse. |
Sherman, Carl |
|
Jan 1, 2007 |
1125 |
| CUtLASS findings interesting but inconclusive. |
Sullivan, Michele G. |
Clinical report |
Nov 1, 2006 |
758 |
| Study questions value of second-generation drugs in AD. |
Kilgore, Christine |
Clinical report |
Nov 1, 2006 |
758 |
| CATIE highlights metabolic issues. |
MacNeil, Jane Salodof |
|
Oct 1, 2006 |
765 |
| Agents compared for first-episode psychosis. |
McNamara, Damian |
|
Oct 1, 2006 |
625 |
| Rivastigmine good choice for Parkinson's dementia. |
Sullivan, Michele G. |
|
Sep 1, 2006 |
453 |
| Thinking on atypical dosages has changed: survey shows daily dosage of clozapine, risperdone down; trend is upward with olanzapine, quetiapine. |
Sherman, Carl |
|
Jan 1, 2006 |
727 |
| Study raises questions about formularies, antipsychotics. |
Brunk, Doug |
Clinical report |
Dec 1, 2005 |
599 |
| Some developmentally disabled see benefits from aripiprazole. |
Splete, Heidi |
Statistical data |
Nov 1, 2005 |
403 |
| Schizophrenia prodrome therapies show promise: early intervention with antipsychotics and CBT appears to delay or prevent psychotic breaks. |
Mahoney, Diana |
|
Oct 1, 2005 |
1314 |
| Treating Alzheimer's agitation. |
Foley, Kevin |
Brief article |
Oct 1, 2005 |
167 |
| Anxiety in bipolar disorder: data on cotreatment are lacking, but anecdotally, antimanics and antipsychotics have proven useful. |
Sherman, Carl |
|
Oct 1, 2005 |
1085 |
| Watch for TD in children and teens. |
Schopick, David |
|
Jul 1, 2005 |
661 |
| Aripiprazole gets broader approval for treatment of bipolar I disorder. |
Sherman, Carl |
Brief Article |
Apr 1, 2005 |
234 |
| Atypicals may mean metabolic changes for youth. |
Mahoney, Diana |
|
Apr 1, 2005 |
553 |
| Atypical antipsychotics show promise for bipolar children. |
Sullivan, Michele G. |
|
Apr 1, 2005 |
525 |
| Newer antipsychotics, hyperlipidemia. |
Foley, Kevin |
Brief Article |
Mar 1, 2005 |
167 |
| Atypical antipsychotics in youth: use caution. |
Mahoney, Diana |
|
Feb 1, 2005 |
759 |
| Novel antipsychotics found effective in bipolar disorder. |
Sullivan, Michele G. |
|
Jan 1, 2005 |
501 |
| Aripiprazole: dosing tips and prescribing pearls. |
|
|
Jan 1, 2005 |
397 |
| Optimal dose offers the most: leveraging secondary pharmacologic actions of atypical antipsychotics. |
Shayegan, Darius K. |
|
Jan 1, 2005 |
467 |
| Choose atypicals for early onset schizophrenia: two drawbacks are the need for slow titration with younger patients and the high cost of newer agents. |
Walsh, Nancy |
|
Jan 1, 2005 |
908 |
| Diabetes risk and antipsychotics. |
Foley, Kevin |
Brief Article |
Nov 1, 2004 |
163 |
| High-dose ziprasidone effective for treatment-resistant schizophrenia. |
Finn, Robert |
|
Nov 1, 2004 |
437 |
| FDA approves aripiprazole for acute bipolar mania. |
Finn, Robert |
|
Nov 1, 2004 |
506 |
| Managing alcohol withdrawal. |
Foley, Kevin |
Brief Article |
Sep 1, 2004 |
151 |
| Five newer atypicals appear equally effective for mania. |
Finn, Robert |
Brief Article |
Sep 1, 2004 |
249 |
| Adjunctive olanzapine for OCD. |
Evans, Jeff |
Brief Article |
Jun 1, 2004 |
129 |
| Higher-dose atypical regimens are becoming more common: economic pressures distorting Tx. (treatment). |
Sherman, Carl |
|
Oct 1, 2003 |
514 |
| Genetic variation can cloud schizophrenia Tx: African american patients. (treatment). |
Zoler, Mitchel L. |
|
Sep 1, 2003 |
548 |
| Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia. (Case Report). |
Torres, Rafael A. |
|
Jul 1, 2003 |
2216 |
| Wait 6-8 weeks before switching antipsychotics. (Don't Give up Too Soon). |
Boschert, Sherry |
|
Jul 1, 2003 |
378 |
| Long-acting, injectable risperidone on horizon. (Approval Expected This Year). |
Boschert, Sherry |
|
Jul 1, 2003 |
595 |
| Practical psychopharmacology. (Atypical Antipsychotics). |
Sherman, Carl |
|
Apr 1, 2003 |
999 |
| Combining antipsychotics. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Feb 1, 2003 |
144 |
| Ethnicity may affect antipsychotic Rx response. (South African Study). |
Mahoney, Diana |
|
Oct 1, 2002 |
670 |
| Study finds adjunctive divalproex benefits acute schizophrenia. (First Double-Blind Frial). |
Walsh, Nancy |
|
Sep 1, 2002 |
329 |
| Bipolar disorder in pregnancy. (Guest Editorial). |
Cohen, Dr. Lee |
Brief Article |
Jul 1, 2002 |
802 |
| Involuntary medication of criminals problematic for U.S. courts. (Psychiatric Testimony Plays Crucial Role). |
Boughton, Barbara |
Brief Article |
Jul 1, 2002 |
599 |
| The doctors' dilemma. (Comments). |
|
Brief Article |
May 13, 2002 |
363 |
| Ziprasidone label clarifies contraindicated drugs. (Manufacturer Cites Misinterpretations). |
Mechcatie, Elizabeth |
Brief Article |
May 1, 2002 |
549 |
| PSY4 Successful treatment of an adult with self-mutilation by treatment with quetiapine. (Psychiatry and Neurology). |
|
Brief Article |
Dec 1, 2001 |
777 |
| Data Reanalysis Suggests Optimal Dose for Atypical Antipsychotics. |
SHERMAN, CARL |
|
Sep 1, 2001 |
373 |
| Catatonia Often Is Overlooked, Ineptly Treated. |
SHERMAN, CARL |
|
Jul 1, 2001 |
509 |
| Environmental Issues a Factor in Youth Prescribing. |
IMPERIO, WINNIE ANNE |
|
Jul 1, 2001 |
571 |
| Schizophrenia drugs: a case for tapering. |
Bower, Bruce |
Brief Article |
Mar 25, 1995 |
515 |
|
